PD

Priyanka Dhairyasheel Mandlik

Active Director Director DIN 07702684
DIN 07702684 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyanka Dhairyasheel Mandlik

Data last updated:

Priyanka Dhairyasheel Mandlik is a Director at Shrudhan Pharma Private Limited (since 2017). The company operates in Pharma.

DIN 07702684
Primary Designation Director
Industry Pharma
First Appointment 18 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shrudhan Pharma Private Limited U74999PN2017PTC168008
Director18 Jan 20172017Active

Board colleagues of Priyanka Dhairyasheel Mandlik

Directorship timeline

Open interactive timeline →
Shrudhan Pharma Private Limited
Premium access

Shareholding and investment profile for Priyanka Dhairyasheel Mandlik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Dhairyasheel Mandlik

Priyanka Dhairyasheel Mandlik currently holds 1 directorship: Shrudhan Pharma Private Limited (Director, since 18 Jan 2017).

Priyanka Dhairyasheel Mandlik was first appointed on 18 Jan 2017 as Director at Shrudhan Pharma Private Limited.

The current boards of Priyanka Dhairyasheel Mandlik's companies include Sanjay Raghunath Shinde (Shrudhan Pharma Private Limited), Uday Mahadeorao Mandlik (Shrudhan Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available